Research Overview

Their research group focuses on developing advanced therapeutic systems by integrating engineering, biology, and pharmaceutical sciences. Specifically, Shaw focuses on engineered living therapies, including the development of cell-based and bioengineered therapeutic platforms with potential applications in cancer, autoimmune diseases, and regenerative medicine. 

He is also experienced in developing advanced drug delivery systems, including lipid-based nanoparticles and targeted delivery platforms, exploring how to improve therapeutic efficacy, stability, and precision targeting. 

His previous research utilized microfluidic technologies to design and optimize drug delivery systems. This includes controlled fabrication of nanoparticles and exploration of micro-scale engineering approaches for biomedical applications.